<DOC>
	<DOCNO>NCT01165723</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics pharmacodynamics PF-04472429 administer intravenously healthy adult volunteer .</brief_summary>
	<brief_title>A Clinical Study Evaluating The Safety And Tolerability Of PF-04427429 In Healthy Adult Volunteers . The Pharmacokinetics And Pharmacodynamics Of PF-04427429 Will Also Be Investigated</brief_title>
	<detailed_description />
	<criteria>Healthy male subject age 18 50 year inclusive . ( healthy define non clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test ) Body mass index ( BMI ) 17.5 30.5 kg/m2 ; total body weight 50 100kg inclusive Evidence personally sign date informed consent document indicate subject ( legally acceptable representative ) inform pertinent aspect trial Evidence history clinically significant haematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , genitourinary , psychiatric , neurologic allergic disease ( include drug allergy , exclude untreated symptomatic , seasonal allergy time dose ) History febrile illness within 5 day prior first dose A positive urine drug screen</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacodynamics</keyword>
	<keyword>chronic pain</keyword>
</DOC>